C Olier

Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)

Thomas Bachelot, Eva Ciruelos, Fabio Puglisi et al. · Annals of Oncology · 2019 · 111 citations · Full text

Metastatic Breast Cancer, Breast Oncology, Medicine +7

A phase II randomized, multicenter, open-label trial of continuing adjuvant temozolomide beyond 6 cycles in patients with glioblastoma (GEINO 14-01)

Carmen Balañá, María Ángeles Vaz Salgado, Juan Manuel Sepúlveda-Sánchez et al. · Neuro-Oncology · 2020 · 103 citations · Full text

Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication

David Miles, Eva Ciruelos, Fabio Puglisi et al. · Annals of Oncology · 2021 · 83 citations · Full text

MA10.01 Antibiotic Use and PD-1 Inhibitors: Shorter Survival in Lung Cancer, Especially When Given Intravenously. Type of Infection Also Matters

Xabier Mielgo-Rubio, L.E. Chara, M.J. Sotelo-Lezama et al. · Journal of Thoracic Oncology · 2018 · 29 citations

Ma10.01 Antibiotic Use, Antibiotics, Health Sciences +10

Polymorphisms in <i>ABCB1</i> and <i>CYP19A1</i> genes affect anastrozole plasma concentrations and clinical outcomes in postmenopausal breast cancer patients

Guillermo Gervasini, Carlos Jara, C Olier et al. · British Journal of Clinical Pharmacology · 2016 · 28 citations · Full text